These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 12971208
41. Rubella vaccination programme in Malaysia: analysis of a seroprevalence study in an antenatal clinic. Sekawi Z, Muizatul WM, Marlyn M, Jamil MA, Ilina I. Med J Malaysia; 2005 Aug; 60(3):345-8. PubMed ID: 16379190 [Abstract] [Full Text] [Related]
42. Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study. Tamirat B, Hussen S, Shimelis T. BMJ Open; 2017 Oct 05; 7(10):e016824. PubMed ID: 28982820 [Abstract] [Full Text] [Related]
43. Seroprevalence of rubella virus antibodies among pregnant women in the Center and South-West regions of Cameroon. Taku NA, Ndze VN, Abernathy E, Hao L, Waku-Kouomou D, Icenogle JP, Wanji S, Akoachere JKT. PLoS One; 2019 Oct 05; 14(11):e0225594. PubMed ID: 31751431 [Abstract] [Full Text] [Related]
44. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Seker S, Abasiyanik MF, Salih BA. Saudi Med J; 2004 May 05; 25(5):575-9. PubMed ID: 15138523 [Abstract] [Full Text] [Related]
45. [Acute rubella virus infection in women of reproductive age in Vojvodina 1994-1995]. Milosevic V, Jerant-Patić V, Mrda i E, Hrnjaković-Cvjetković I. Med Pregl; 1997 May 05; 50(3-4):81-5. PubMed ID: 9229689 [Abstract] [Full Text] [Related]
46. Primary rubella virus infection: prevalence and relationship to pregnancy wastage. Singla N, Jindal N, Aggarwal A. Indian J Pathol Microbiol; 2003 Oct 05; 46(4):688-9. PubMed ID: 15025383 [Abstract] [Full Text] [Related]
47. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey? Aksakal FN, Maral I, Cirak MY, Aygun R. Jpn J Infect Dis; 2007 Jul 05; 60(4):157-60. PubMed ID: 17642522 [Abstract] [Full Text] [Related]
48. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
50. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India. Vijayalakshmi P, Anuradha R, Prakash K, Narendran K, Ravindran M, Prajna L, Brown D, Robertson SE. Bull World Health Organ; 2004 Apr 17; 82(4):259-64. PubMed ID: 15259254 [Abstract] [Full Text] [Related]
51. Seroprevalence and risk factors for rubella infection in pregnant women attending a tertiary hospital in Kano-Nigeria. Zahradeen SU, Muhammad ID, Adamou N, Rabiu A, Yusuf MA, Shuaibu SAD, Ibrahim G. Pan Afr Med J; 2023 Apr 17; 46():97. PubMed ID: 38405097 [Abstract] [Full Text] [Related]
52. Seroepidemiology study of rubella virus antibodies among neonates and pregnant women at hospitals in Henan province, China. Wang X, Han Y, Li C, Wang M, Yang B, Zhang X, Zhao L. J Med Virol; 2023 Dec 17; 95(12):e29340. PubMed ID: 38131155 [Abstract] [Full Text] [Related]
53. Rubella in Umbria (Italy): serological assessment of immunity in adult women and congenital rubella detection after 1978. Iorio AM, Greco M, Trabalza N, Cappuccini B, Barboni G, Perocchi F. Boll Ist Sieroter Milan; 1981 Dec 17; 60(4):278-83. PubMed ID: 7326102 [Abstract] [Full Text] [Related]
54. [Rubella in Vojvodina. VI. Serologic status of women of reproductive age during the time of endemic manifestations of rubella 1978-1985]. Durisić S, Milosević V, Vuković B, Seguljev Z, Stefanović S. Med Pregl; 1993 Dec 17; 46(9-10):319-22. PubMed ID: 7997205 [Abstract] [Full Text] [Related]
55. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran. Tabatabaee M, Tayyebi D. J Matern Fetal Neonatal Med; 2009 Jun 17; 22(6):517-21. PubMed ID: 19350446 [Abstract] [Full Text] [Related]
56. Seroprevalence of rubella antibodies among antenatal population attending a tertiary level hospital in Dhaka City. Ashrafunnessa, Khatun S, Islam MN, Chowdhury S. Bangladesh Med Res Counc Bull; 2000 Dec 17; 26(3):75-81. PubMed ID: 11766002 [Abstract] [Full Text] [Related]
57. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women. Hofmann J, Liebert UG. J Virol Methods; 2005 Dec 17; 130(1-2):66-71. PubMed ID: 16024097 [Abstract] [Full Text] [Related]
58. Rubella in pregnancy in Israel: 15 years of follow-up and remaining problems. Fogel A, Barnea BS, Aboudy Y, Mendelson E. Isr J Med Sci; 1996 May 17; 32(5):300-5. PubMed ID: 8641868 [Abstract] [Full Text] [Related]
59. Rubella vaccination of unknowingly pregnant women: the São Paulo experience, 2001. Sato HK, Sanajotta AT, Moraes JC, Andrade JQ, Duarte G, Cervi MC, Curti SP, Pannuti CS, Milanez H, Pessoto M, Flannery B, Oselka GW, São Paulo Study Group for Effects of Rubella Vaccination During Pregnancy. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S737-44. PubMed ID: 21954275 [Abstract] [Full Text] [Related]
60. Evaluation of a commercial rubella IgM assay for use on oral fluid samples for diagnosis and surveillance of congenital rubella syndrome and postnatal rubella. Vijaylakshmi P, Muthukkaruppan VR, Rajasundari A, Korukluoglu G, Nigatu W, L A Warrener, Samuel D, Brown DW. J Clin Virol; 2006 Dec 01; 37(4):265-8. PubMed ID: 17049919 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]